OTC Markets OTCQB - Delayed Quote USD

Healthy Extracts Inc. (HYEX)

Compare
2.6000 0.0000 (0.00%)
As of October 16 at 4:00 PM EDT. Market Open.
Loading Chart for HYEX
DELL
  • Previous Close 2.6000
  • Open 2.6000
  • Bid 2.6300 x 40000
  • Ask 3.2500 x 40000
  • Day's Range 2.6000 - 2.6000
  • 52 Week Range 0.9106 - 7.2000
  • Volume 100
  • Avg. Volume 96
  • Market Cap (intraday) 7.783M
  • Beta (5Y Monthly) 2.04
  • PE Ratio (TTM) --
  • EPS (TTM) -0.4600
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Healthy Extracts Inc., through its subsidiaries, engages in the acquiring, development, marketing, and distribution of plant-based nutraceuticals in the United States. The company's proprietary and patented products target categories within the nutraceuticals market, such as heart, brain, and immune health. It offers heart and immune health products, including bergamot-based products in tablet and capsule form; and plant-based health technology neuro-products that improves brain health, including memory, cognition, focus, and neuro-energy. The company was formerly known as Grey Cloak Tech Inc. and changed its name to Healthy Extracts Inc. in October 2020. Healthy Extracts Inc. was incorporated in 2014 and is headquartered in Henderson, Nevada.

www.healthyextractsinc.com

4

Full Time Employees

December 31

Fiscal Year Ends

Recent News: HYEX

View More

Performance Overview: HYEX

Trailing total returns as of 10/17/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

HYEX
63.89%
S&P 500
22.45%

1-Year Return

HYEX
57.46%
S&P 500
33.54%

3-Year Return

HYEX
60.61%
S&P 500
30.62%

5-Year Return

HYEX
52.90%
S&P 500
95.36%

Compare To: HYEX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HYEX

View More

Valuation Measures

Annual
As of 10/16/2024
  • Market Cap

    7.78M

  • Enterprise Value

    8.67M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.67

  • Price/Book (mrq)

    19.46

  • Enterprise Value/Revenue

    3.01

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -47.72%

  • Return on Assets (ttm)

    -15.95%

  • Return on Equity (ttm)

    -173.87%

  • Revenue (ttm)

    2.88M

  • Net Income Avi to Common (ttm)

    -1.37M

  • Diluted EPS (ttm)

    -0.4600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    148.23k

  • Total Debt/Equity (mrq)

    259.20%

  • Levered Free Cash Flow (ttm)

    1.1M

Company Insights: HYEX

People Also Watch